SCHEMBL15416474

SCHEMBL15416474

CC1(C(=O)O)CCN(c2ncccn2)CC1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
CYP3A4 P08684 8/20 0.54
CYP2C19 P33261 3/20 0.51
KDM4E B2RXH2 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.49
ALDH1A1 P00352 4/20 0.49
MAPK1 P28482 3/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2D6 P10635 5/20 0.49
CYP1A2 P05177 1/20 0.49
TSHR P16473 1/20 0.47
HSD17B10 Q99714 4/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
USP2 O75604 1/20 0.46
LMNA P02545 2/20 0.45
MAPT P10636 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1685314 0.83 MEN1 (0.41) MEN1KMT2ACYP3A4KDM4ESMN1; SMN2
SCHEMBL1282761 0.82 PANK3 (0.45) MEN1KMT2ACYP3A4KDM4E
SCHEMBL22532812 0.81 ALDH1A1 (0.62) MEN1KMT2ACYP3A4CYP2C19KDM4E
SCHEMBL15416130 0.81 MEN1 (0.55) MEN1KMT2ACYP3A4CYP2C19KDM4E
SCHEMBL16797064 0.80 MEN1 (0.38) MEN1KMT2ACYP3A4CYP2C19KDM4E
SCHEMBL21868482 0.79 MEN1 (0.54) MEN1KMT2ACYP3A4CYP2C19KDM4E
SCHEMBL15416239 0.79 MEN1 (0.54) MEN1KMT2ACYP3A4CYP2C19KDM4E
SCHEMBL28247431 0.79 CYP3A4 (0.50) MEN1KMT2ACYP3A4CYP2C19KDM4E
SCHEMBL20565247 0.75 HSD17B10 (0.47) MEN1KMT2ACYP3A4CYP2C19KDM4E
SCHEMBL1292596 0.75 DGAT1 (0.38) MEN1KMT2ACYP3A4CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872511-A1 IMIDAZOPYRAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB Biopharma SPRL (BE) 2015-05-20 EP disclosed
WO-2014009296-A1 IMIDAZOPYRAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB PHARMA S.A. (BE) 2014-01-16 WO disclosed